The Ets factor Spi-B is a direct critical target of the coactivator OBF-1
- Boris Bartholdy*,†,
- Camille Du Roure*,
- Alain Bordon*,
- Dianne Emslie‡,
- Lynn M. Corcoran‡, and
- Patrick Matthias*,§
- *Friedrich Miescher Institute for Biomedical Research, Novartis Research Foundation, Maulbeerstrasse 66, CH-4058 Basel, Switzerland; and
- ‡The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia
-
Edited by Richard A. Flavell, Yale University School of Medicine, New Haven, CT, and approved June 15, 2006 (received for review December 6, 2005)
Abstract
OBF-1 (Bob.1, OCA-B) is a lymphoid-specific transcriptional coactivator that associates with the transcription factors Oct-1 or Oct-2 on the conserved octamer element present in the promoters of several ubiquitous and lymphoid-specific genes. OBF-1-deficient mice have B cell-intrinsic defects, lack germinal centers, and have severely impaired immune responses to T cell-dependent antigens. Crucial genes that are regulated by OBF-1 and that might explain the observed phenotype of OBF-1 deficiency have remained elusive to date. Here we have generated transgenic mice expressing OBF-1 specifically in T cells and examined these together with mice lacking OBF-1 to discover transcriptional targets of this coactivator. Using microarray analysis, we have identified the Ets transcription factor Spi-B as a direct target gene critically regulated by OBF-1 that can help explain the phenotype of OBF-1-deficient mice. Spi-B has been implicated in signaling pathways downstream of the B cell receptor and is essential for germinal center formation and maintenance. The present findings establish a hierarchy between these two factors and provide a molecular link between OBF-1 and B cell receptor signaling.
Footnotes
- §To whom correspondence should be addressed. E-mail: patrick.matthias{at}fmi.ch
-
↵ †Present address: Division of Hematology/Oncology, Beth Israel Hospital, Harvard Medical School, Boston, MA 02215.
-
Author contributions: B.B., C.D.R., A.B., and P.M. designed research; B.B., C.D.R., A.B., and D.E. performed research; D.E. and L.M.C. contributed new reagents/analytic tools; B.B., C.D.R., A.B., and P.M. analyzed data; and B.B. and P.M. wrote the paper.
-
Conflict of interest statement: No conflicts declared.
-
This paper was submitted directly (Track II) to the PNAS office.
- Abbreviations:
- BCR,
- B cell receptor;
- GC,
- germinal center;
- PMA,
- phorbol myristic acetate (phorbol 12-tetradecanoate 13-acetate12-O-tetradecanoylphorbol-13-acetate);
- Pn,
- promoter n;
- PNA,
- peanut agglutinin;
- TD,
- T cell-dependent.
-
Freely available online through the PNAS open access option.
- © 2006 by The National Academy of Sciences of the USA





